Inhibikase Therapeutics Inc. (IKT)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
2. 11
+0.1
+4.9751%
$
271.99M Market Cap
- P/E Ratio
- Div Yield
1.74M Volume
-1.77 Eps
$ 2.01
Previous Close 
Want to track IKT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Inhibikase Therapeutics Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| EW Edward White HC Wainwright & Co. | -40,557.93 | $118,730.97 | $83,549.34 | $35,181.63 | 29.63% |
